163 related articles for article (PubMed ID: 37483852)
41. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
[TBL] [Abstract][Full Text] [Related]
42. Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.
Schuettfort VM; D Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; Sari Motlagh R; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Chlosta P; Babjuk M; Deuker M; Moschini M; Shariat SF; Pradere B
Urol Oncol; 2021 Apr; 39(4):235.e5-235.e14. PubMed ID: 33189530
[TBL] [Abstract][Full Text] [Related]
43. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF
Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
[TBL] [Abstract][Full Text] [Related]
44. Clinical Significance of Pre-treated Neutrophil-Lymphocyte Ratio in the Management of Urothelial Carcinoma: A Systemic Review and Meta-Analysis.
Suh J; Jung JH; Jeong CW; Kwak C; Kim HH; Ku JH
Front Oncol; 2019; 9():1365. PubMed ID: 31921631
[No Abstract] [Full Text] [Related]
45. Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
Laukhtina E; Schuettfort VM; D'Andrea D; Pradere B; Mori K; Quhal F; Sari Motlagh R; Mostafaei H; Katayama S; Grossmann NС; Rajwa P; Zeinler F; Abufaraj M; Moschini M; Zimmermann K; Karakiewicz PI; Fajkovic H; Scherr D; Compérat E; Nyirady P; Rink M; Enikeev D; Shariat SF
Mol Carcinog; 2022 Jan; 61(1):5-18. PubMed ID: 34587660
[TBL] [Abstract][Full Text] [Related]
46. The effect of different timing of blood transfusion on oncological outcomes of patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis.
Ma SY; An Y; Sun JX; Xu MY; Liu CQ; Xu JZ; Zhong XY; Zeng N; He HD; Xia QD; Wang SG
Front Oncol; 2023; 13():1223592. PubMed ID: 37719020
[TBL] [Abstract][Full Text] [Related]
47. The Impact of Lymphovascular Invasion on Risk of Upstaging and Lymph Node Metastasis at the Time of Radical Cystectomy.
Werntz RP; Smith ZL; Packiam VT; Smith N; Steinberg GD
Eur Urol Focus; 2020 Mar; 6(2):292-297. PubMed ID: 30297221
[TBL] [Abstract][Full Text] [Related]
48. Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.
Abufaraj M; Shariat SF; Foerster B; Pozo C; Moschini M; D'Andrea D; Mathieu R; Susani M; Czech AK; Karakiewicz PI; Seebacher V
World J Urol; 2018 Feb; 36(2):231-240. PubMed ID: 29127452
[TBL] [Abstract][Full Text] [Related]
49. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
Rink M; Lee DJ; Kent M; Xylinas E; Fritsche HM; Babjuk M; Brisuda A; Hansen J; Green DA; Aziz A; Cha EK; Novara G; Chun FK; Lotan Y; Bastian PJ; Tilki D; Gontero P; Pycha A; Baniel J; Mano R; Ficarra V; Trinh QD; Tagawa ST; Karakiewicz PI; Scherr DS; Sjoberg DD; Shariat SF;
BJU Int; 2013 Mar; 111(3 Pt B):E30-6. PubMed ID: 22938654
[TBL] [Abstract][Full Text] [Related]
50. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
51. Prognostic nutritional index combined with NLR to construct a survival prediction model and decision analysis of patients with muscle-invasive bladder cancer after surgery.
Wang J; Shi H; Fan Z; Yang J; Zheng Y; Zeng D; Zhang J; Hai B
Cancer Med; 2023 Jul; 12(13):14207-14224. PubMed ID: 37199384
[TBL] [Abstract][Full Text] [Related]
52. The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes.
Moschini M; Shariat SF; Abufaraj M; Soria F; Klatte T; Croce G; Mattei A; Damiano R; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
Urol Oncol; 2017 Apr; 35(4):151.e17-151.e23. PubMed ID: 27932269
[TBL] [Abstract][Full Text] [Related]
53. Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy.
Gierth M; Mayr R; Aziz A; Krieger S; Wullich B; Pycha A; Lodde M; Salvadori U; Bründl J; Fritsche HM; Hofstädter F; Pawlik MT; Otto W; May M; Burger M; Denzinger S
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1819-26. PubMed ID: 25832016
[TBL] [Abstract][Full Text] [Related]
54. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.
Turker P; Bostrom PJ; Wroclawski ML; van Rhijn B; Kortekangas H; Kuk C; Mirtti T; Fleshner NE; Jewett MA; Finelli A; Kwast TV; Evans A; Sweet J; Laato M; Zlotta AR
BJU Int; 2012 Sep; 110(6):804-11. PubMed ID: 22321341
[TBL] [Abstract][Full Text] [Related]
55. Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases?
Manoharan M; Katkoori D; Kishore TA; Jorda M; Luongo T; Soloway MS
World J Urol; 2010 Apr; 28(2):233-7. PubMed ID: 19597735
[TBL] [Abstract][Full Text] [Related]
56. Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy.
Salama A; Abdelmaksoud AM; Shawki A; Abdelbary A; Aboulkassem H
Clin Genitourin Cancer; 2016 Feb; 14(1):e43-7. PubMed ID: 26363827
[TBL] [Abstract][Full Text] [Related]
57. Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience.
Moschini M; Karnes RJ; Sharma V; Gandaglia G; Fossati N; Dell'Oglio P; Cucchiara V; Capogrosso P; Shariat SF; Damiano R; Salonia A; Montorsi F; Briganti A; Gallina A; Colombo R
Eur J Surg Oncol; 2016 May; 42(5):735-43. PubMed ID: 26927300
[TBL] [Abstract][Full Text] [Related]
58. Association between early change in neutrophil-to-lymphocyte ratio after radical cystectomy and treatment outcomes.
Herzberg H; Lifshitz K; Golan S; Baniel J; Malshy K; Hoffman A; Amiel GE; Zreik R; Freifeld Y; Dekel Y; Lasmanovich R; Lazarovich A; Rosenzweig B; Dotan Z; Yossepowitch O; Mano R
BJU Int; 2022 Oct; 130(4):470-477. PubMed ID: 35476895
[TBL] [Abstract][Full Text] [Related]
59. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
[TBL] [Abstract][Full Text] [Related]
60. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
Vartolomei MD; Mathieu R; Margulis V; Karam JA; Rouprêt M; Lucca I; Mbeutcha A; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Rioux-Leclercq N; Haitel A; Bensalah K; Rink M; Briganti A; Xylinas E; Shariat SF
World J Urol; 2017 Jan; 35(1):121-130. PubMed ID: 27209168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
